Rationale for pertussis booster vaccination throughout life in Europe.
about
The pertussis enigma: reconciling epidemiology, immunology and evolutionPertussis: Microbiology, Disease, Treatment, and Prevention.Epidemiology of pertussis in Casablanca (Morocco): contribution of conventional and molecular diagnosis toolsc-di-GMP enhances protective innate immunity in a murine model of pertussisDeciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand.Vaccine-preventable diseases in Europe: where do we stand?Seroprevalence of pertussis in Senegal: a prospective studyThe disease burden of pertussis in adults 50 years old and older in the United States: a retrospective studyPertussis re-emergence in the post-vaccination eraThe social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young.Combating pertussis resurgence: One booster vaccination schedule does not fit allPertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan.Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.Vaccination recommendations for Germany.The estimated incidence of pertussis in people aged 50 years old in the United States, 2006-2010.Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013.Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary careStructure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children.Lessons learned and applied: what the 20th century vaccine experience can teach us about vaccines in the 21st centuryWhooping cough dynamics in Chile (1932-2010): disease temporal fluctuations across a north-south gradient.Self-boosting vaccines and their implications for herd immunityNew insights into rotavirus vaccines.Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.The resurgence of mumps and pertussisIssues in pediatric vaccine-preventable diseases in low- to middle-income countriesAdult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage.Estimated incidence of pertussis in people aged <50 years in the United States.Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: an open randomized controlled trial in Japan.Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.Toward a new vaccine for pertussisHow to fight pertussis?Is adolescent pertussis vaccination preferable to natural booster infections?A critical literature review of health economic evaluations in pertussis booster vaccination.Shortened interval between tetanus vaccines.Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around....Strategies to control pertussis in infants.Respiratory infections in the military.Epidemiology of whooping cough & typing of Bordetella pertussis.
P2860
Q26772095-8486BF62-E193-44DA-8944-18C914B7EE48Q30251684-4E7156BF-B5ED-47B6-B2BE-C09600624C5EQ33696832-79482F4F-F0F6-449E-A288-6A5DABCF05B7Q34343647-A8ABABC3-8BB7-48FF-B592-C0F2FFFA4AECQ34345687-9CDCA019-89A2-44F3-9A1C-7384E2CA9954Q34426206-EFBFC1DE-316B-4105-A146-FE1D3FAF7D56Q34465419-34F74E4D-A37A-46C1-96F8-2F7AE454E026Q34560049-7722DB5E-9431-42EF-95E3-A2EB4857AB74Q34636630-9CBD1FCD-8F4B-4C85-89A6-30727700706EQ35022663-AA427058-A25C-4E84-809D-270438F2BBD4Q35062572-6424067D-D4AE-41E7-86A8-3B156208C921Q35068485-5B5A0E8F-92C1-4A8A-A1CA-E06CDBA4F7A8Q35193398-432B2C99-66DF-4113-BE2B-E15611339724Q35591138-C9006132-E32B-415C-ACC7-C326788A9E7FQ35846238-FC03C68D-26AD-4E98-9539-6C77D352123FQ36039358-59B708BD-E38A-454F-8F63-501488C36F71Q36092616-E8170AA3-5F00-4516-8ECA-3A50A9AF0194Q36147897-D86F594B-3106-457D-9ED3-ABC50E60A31BQ36334529-B97BC7F0-4859-43B0-8D01-74BAD69F4DF0Q36378601-0761B95B-24F3-45F8-8C49-77ADABA390A1Q36391852-AB1C2302-8736-4F6C-BFB4-287D608DF519Q36416536-55F706DE-8924-46F6-9339-C352D46A73F8Q36471228-65D3DF53-B9E7-4197-B636-A789FB4AABDDQ36552854-6A611F35-0FB2-4B9A-841C-CF047CE846B5Q36558999-C7B86961-C49B-4C6A-8E7A-C1E5FBEEAE73Q37130711-CB4F9352-0409-4640-BF10-857B91E62339Q37264972-1A21DC4D-8B81-4C4D-AB54-A267941537BAQ37342230-6A9C413D-83CF-4EF9-B646-D20E0C21BC33Q37375965-47901146-D4BE-495C-A9B2-9E28E40BA49DQ37469300-77BF0E05-05AF-4E83-BA63-6460815E1C11Q37545038-B28CDB2F-B857-4245-8B0A-FC2CEECA5318Q37628007-360F8D08-7716-4C9E-A2C8-FEC02165D390Q37668385-C011D593-52FD-43A7-84F8-A3CAB58F5213Q37960125-04F2DC73-A5B2-415A-AC28-15F4EF545B24Q37978907-3AD2FC7F-E9DC-4E5D-808E-593D7CE76C41Q38016387-42D5F46F-235E-4846-9EC4-0C1A41E0BD88Q38068468-90099CD9-922A-4B80-A195-72CD89F8887AQ38108706-B789C450-4A18-446F-8F48-626037CA9B8EQ38151079-1B9FCBEE-FFB6-4EDE-8C31-C85716D34389Q38160533-A060FDAF-E620-41B5-AF18-E002DE3D6905
P2860
Rationale for pertussis booster vaccination throughout life in Europe.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rationale for pertussis booster vaccination throughout life in Europe.
@ast
Rationale for pertussis booster vaccination throughout life in Europe.
@en
Rationale for pertussis booster vaccination throughout life in Europe.
@nl
type
label
Rationale for pertussis booster vaccination throughout life in Europe.
@ast
Rationale for pertussis booster vaccination throughout life in Europe.
@en
Rationale for pertussis booster vaccination throughout life in Europe.
@nl
prefLabel
Rationale for pertussis booster vaccination throughout life in Europe.
@ast
Rationale for pertussis booster vaccination throughout life in Europe.
@en
Rationale for pertussis booster vaccination throughout life in Europe.
@nl
P2093
P50
P1476
Rationale for pertussis booster vaccination throughout life in Europe
@en
P2093
John Roord
Jussi Mertsola
Pierre Van Damme
Ulrich Heininger
P304
P356
10.1016/S1473-3099(11)70007-X
P577
2011-05-18T00:00:00Z